Dottoressa Maida Bada

Biografia

La dott.ssa Maida Bada si laurea in medicina e chirurgia presso l’università Campus Bio Medico di Roma con lode discutendo la tesi “Adoption of standardized care protocols in patients undergoing radical robotic prostatectomy: comparison and outcomes”.

Ad aprile 2020 si specializza in urologia, con lode, discutendo la tesi “The role of cryotherapy in the management of small renal masses: trifecta outcomes in long term follow-up”.

La sua insaziabile voglia di conoscenza, unita all’irrefrenabile caparbietà nell’approfondire la medicina ed a studiarla a 360 gradi, l’ha portata ad arricchire il suo curriculum vitae con esperienze lavorative che, tutt’oggi, coltiva con passione e determinazione.

DURANTE IL PERCORSO FORMATIVO HA LAVORATO PRESSO:

reparto di urologia pediatrica presso l’ospedale Bambino Gesù di Roma, interessandosi all’urologia pediatrica e sviluppando importanti conoscenze in materia
reparto di urologia presso l’ospedale S. Bassiano di Bassano del Grappa, eccellenza italiana in urologia robotica
reparto di urologia presso l’ospedale di Abano Terme

reparto di urologia presso l’ospedale di Vasto (CH), Lanciano e Chieti
Dirigente Medico presso unità operativa complessa di urologia Ospedale Sacrocuore Don Calabria di Negrar (VR)
Medico presso UROS ASSOCIATS – Barcellona (Spagna)

Attività clinica - Urologia

Tumori del rene

Tumori della prostata

Tumori via urinaria - uretere

Tumori della vescica

Esame Urodinamico completo

Calcolosi reno ureterale

Vescica iperattiva

Incontinenza urinaria femminile e maschile

Riabilitazione del pavimento pelvico

Urologia pediatrica

Infezioni del tratto urinario

Infertilità maschile

Trattamento iperplasia prostatica benigna con laser

Pubblicazioni

La dottoressa Maida Bada si é sempre occupata di ricerca scientifica e la sua passione per l’urologia la porta ad aggiornarsi costantemente frequentando i più importanti congressi di urologia ed a prestare importanti contributi alla ricerca scientifica.

1. Work up of incidental adrenal mass: state of the art. Urologia 2016 (doi: 10.5301/uro.5000176)
2. “Hair in the bladder”: an unusual finding. J Endourol Case Rep. 2017. (doi: 10.1089/cren.2017.0012)
3. Abiraterone Acetate for treatment of metastatic castration-resistant Prostate cancer in chemotherapy- naive patients: an Italian analysis of patients’satisfaction. Clin genitourin Cancer 2017. (doi: 10.1016/j.clgc.2017.04.003)
4. Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study.BMC Cancer 2017. (doi: 10.1186/s12885-017-3755-x)
5. Primary Vaginal Calculus in a Woman with Disability: Case Report and Literature Review.J Endourol Case Rep. 2017. (doi: 10.1089/cren.2017.0100)
6. Adherence to the EAU guidelines on Penile Cancer Treatment:: European, multicentre, retrospective study. J Cancer Res Clin Oncol. 2019. ( doi: 10.1007/s00432-019-02864-9)
7. Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience. Urologia. 2018. (doi: 10.1177/0391560318759258)
8. Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies. Ther Adv Urol. 2018 (doi: 10.1177/1756287218786160)
9. Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study. World J Urol. 2019 (doi: 10.1007/s00345-018-2549-3)
10. Adherence to hormonal deprivation therapy in prostate cancer in clinical practice: a retrospective, single-centre study. Minerva Urol Nefrol. 2019 (doi: 10.23736/S0393-2249.18.03109-0)
11. Minimally invasive laser treatment of ureterocele. Frontiers in Pediatrics. 2019 ( doi: 10.3389/fped.2019.00106)
12. Glanular Venous Malformation in Pediatric Age: An Uncommon Vascular Disorder. Urology. 2019. (doi: 10.1016/j.urology.2019.05.025)
13. External validation of Cormio nomogram for predicting all prostate cancers and clinically significant prostate cancers. World J Urol. 2020 (doi: 10.1007/s00345-019-03058-1)
14. Retrograde Intra Renal Surgery (RIRS) Versus Percutaneous Nephrolithotomy (PCNL) for Renal Stones >2cm. A Systematic Review and Meta-Analysis. Minerva UroNefro 2020 (doi: 10.23736/S0393-2249.20.03721-2)
15. Laparoscopic radical cystectomy with extracorporeal urinary diversion: a single centre experience with 10 year outcomes. Minerva Urologia 2020. (doi: 10.23736/S0393-2249.20.03850-3)
16. Bowel suture technique for bladder neck recostruction during RALP and impact on early continence recovery. Minerva Urol Nefrol. 2020 (doi: 10.23736/S0393-2249.20.03880-1)
17. The Role of multiparametric resonance and biopsy in prostate cancer detection: comparison with definitive histological report after laparoscopic/robotic radical prostatectomy. Abdominal Radiology. 2020 (doi: 10.1007/s00261-020-02798-8)
18. The role of renal biopsy to improve diagnosis and management of small renal masses: are there predictive factors for detective higher diagnostic rate? The first Italian study of 100 cases. Minerva UroNefro 2021 (doi: 10.23736/S2724-6051.20.03519-5)
19. Ultrasound prostate parameters as predictors of a successful trial without catheter after acute urinary retention in patients ongoing medical treatment for benign prostatic hyperplasia: a prospective multicentre study. Minerva Urol Nefr. 2021 (DOI: 10.23736/S2724-6051.20.04088-6)
20. Introducing the PNL-Trifecta: a proposal for standard reporting outcomes of percutaneous nephrolithotomies. Minerva Urol. Nefr. 2021 (doi: 10.23736/S2724-6051.21.04046-7)
21. Urinary incontinence after planned caesarian hysterectomy for placenta accrete. Urologia Internationalis 2021 ( doi: 10.1159/000518114)
22. The Comparison of imaging and clinical methods to estimate prostate volume: a single-center retrospective study. Internationalis Urologia 2021 (doi: 10.1159/000516681)
23. Conservative management of primary malignant melanoma of the bladder: a case report. Journal of Medical Case Reports 2021 (doi: 10.1186/s13256-020-02602-7)
24. Urologic malignancies: advances in the analysis and interpretation of clinical findings. Future Science 2021 (doi: 10.2144/fsoa-2020-0210)
25. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation. European Journal of surgical Oncology 2021. (doi: 10.1016/j.ejso.2021.04.033)
26. Proact in the management of stress urinary incontinence after radical prostatectomy. What happens after 8 years of follow up? monocentric analysis in 42 patients. J of Basic and Clinical Physiology and Pharmacology. 2022 (doi: 10.1515/jbcpp-2021-0295)
27. Warm ischemia time lenght during on-clamp partial nephrectomy: does it really matter? Minerva Urol Nephrol. 2022 ( doi: 10.23736/S2724-6051.21.04466-9)
28. Introducing trifecta for percutaneous nephrolithotomies: a proposal for standard reporting outcomes after treatment for renal stones. Minerva Urol. Nephron. 2022. (doi: 10.23736/S2724-6051.21.04046-7)
29. External Validation of Yonsei nomogram Predicting Chronic Kidney Disease Development after Partial Nephrectomy: An international, multicenter study. Internatiol journal of Urology. 2023. ( doi: 10.1111/iju.15108)
30. Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in multicenter setting. J Basic Clin Physiol Pharmacol. 2023 (doi: 10.1515/jbcpp-2023-0038)
31. Reliability of nephrolithometric monograms in patients treated with minimally invasive percutaneous nephrolithotomy: A precision study. Asian J Urol. 2023. (doi: 10.1016/j.ajur.2022.02.010)